Tampa, FL, United States of America

David Morse

This inventor holds 1 USPTO granted patent. Top assignee: Wake Forest University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Morse. Retrieved from https://idiyas.com/inventor/david-morse-uxfrl411

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Morse - Innovator in Radiotherapeutic Agents

Introduction

David Morse is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of radiotherapy through his innovative work. His research focuses on developing agents that enhance the effectiveness of cancer treatment.

Latest Patents

David Morse holds a patent for "Radiotherapeutic and Companion Imaging Agents to Target MC1R." This patent represents a crucial advancement in targeting specific receptors in cancer therapy, potentially improving treatment outcomes for patients.

Career Highlights

David is affiliated with Wake Forest University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential impact on cancer treatment methodologies.

Collaborations

David has worked alongside talented colleagues such as Thaddeus Wadas and Narges Tafreshi. Their combined expertise contributes to the innovative research being conducted at Wake Forest University.

Conclusion

David Morse is a dedicated inventor whose work in radiotherapeutic agents is paving the way for advancements in cancer treatment. His contributions are vital to the ongoing efforts to improve patient care and treatment efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…